147 related articles for article (PubMed ID: 161403)
1. [Serious side effects with D-penicillamine therapy for Wilson's disease].
Storch W; Lössner J; Ruchholtz U
Psychiatr Neurol Med Psychol (Leipz); 1979 Sep; 31(9):531-8. PubMed ID: 161403
[TBL] [Abstract][Full Text] [Related]
2. [immunohistologic findings of kidney biopsies in Wilson's disease].
Storch W; Ditscherlein G; Lange E; Lössner J
Z Urol Nephrol; 1980 Mar; 73(3):181-90. PubMed ID: 7434982
[TBL] [Abstract][Full Text] [Related]
3. [The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results].
Trautmann B; Storch W
Pharmazie; 1986 Feb; 41(2):126-7. PubMed ID: 3523546
[TBL] [Abstract][Full Text] [Related]
4. [Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].
Storch W; Berger H
Z Gesamte Inn Med; 1980 Jul; 35(13):567-70. PubMed ID: 7445606
[TBL] [Abstract][Full Text] [Related]
5. Immune complex type glomerulonephritis in cirrhosis of the liver.
Callard P; Feldmann G; Prandi D; Belair MF; Mandet C; Weiss Y; Druet P; Benhamou JP; Bariety J
Am J Pathol; 1975 Aug; 80(2):329-40. PubMed ID: 126021
[TBL] [Abstract][Full Text] [Related]
6. Immune-complex nephritis in bacterial endocarditis.
Perez GO; Rothfield N; Williams RC
Arch Intern Med; 1976 Mar; 136(3):334-6. PubMed ID: 130845
[TBL] [Abstract][Full Text] [Related]
7. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
Kim Y; Vernier RL; Fish AJ; Michael AF
Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
[TBL] [Abstract][Full Text] [Related]
8. Delay in growth and the development of nephritis in rats treated with interferon preparations in the neonatal period.
Gresser I; Morel-Maroger L; Châtelet F; Maury C; Tovey M; Bandu MT; Buywid J; Delauche M
Am J Pathol; 1979 May; 95(2):329-46. PubMed ID: 156503
[TBL] [Abstract][Full Text] [Related]
9. Wilson's disease treated with penicillamine and lupus erythematosus: related or distinct entities?
Dell'era L; Boati E; Nebbia G; Corona F
Minerva Pediatr; 2012 Feb; 64(1):55-7. PubMed ID: 22350045
[TBL] [Abstract][Full Text] [Related]
10. Membraneous glomerulonephritis induced by HB (Australia) antigen-antibody complexes.
Nagy J; Pár A; Bajtai G; Ambrus M; Deák G
Acta Morphol Acad Sci Hung; 1976; 24(1-2):129-38. PubMed ID: 801416
[TBL] [Abstract][Full Text] [Related]
11. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
12. [Modern diagnosis of immune nephritis].
Belovezhdov N; Altunkova I
Vutr Boles; 1979; 18(5):16-20. PubMed ID: 160137
[No Abstract] [Full Text] [Related]
13. [Nephrotic syndrome presumable caused by an complex glomerulonephritis (author's transl)].
Seelig HP; Seelig R; Fischer K; Maurer R; Safer A; Schnitzlein W
Res Exp Med (Berl); 1977 Apr; 169(1):35-55. PubMed ID: 141075
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
15. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
16. Interpretation of immunofluorescent patterns in renal diseases.
Valenzuela R; Deodhar SD
Pathobiol Annu; 1980; 10():183-221. PubMed ID: 7003493
[No Abstract] [Full Text] [Related]
17. [Hypothesis on the basic immune disorders, the originating cause and the development of glomerulonephritis].
Belovezhdov N
Vutr Boles; 1984; 23(3):39-48. PubMed ID: 6464431
[TBL] [Abstract][Full Text] [Related]
18. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
Scheinberg IH; Jaffe ME; Sternlieb I
N Engl J Med; 1987 Jul; 317(4):209-13. PubMed ID: 3600712
[TBL] [Abstract][Full Text] [Related]
19. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
[TBL] [Abstract][Full Text] [Related]
20. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
